泌尿器科機器市場規模、シェア、動向、2030年までの世界予測

泌尿器科機器市場 – 製品（透析、レーザー、結石破砕術、ロボット、気腹器、ガイドワイヤー、カテーテル、ステント、インプラント）、用途（腎臓疾患、がん、骨盤臓器脱、前立腺肥大症、結石）、エンドユーザーおよび地域別 – 2030年までの世界予測

世界の泌尿器科機器市場は、2025年に345億6,000万米ドルと推定され、2030年には462億6,000万米ドルに達すると予測されており、予測期間中の年平均成長率（CAGR）は6.0%です。糖尿病や高血圧などの慢性代謝性疾患や心血管疾患の罹患率の上昇により、迅速な診断評価と外科的介入を必要とする泌尿器疾患の発生率が大幅に増加しています。疾患の進行を防ぎ、患者の転帰を最適化するには、迅速かつエビデンスに基づいた臨床管理が不可欠です。同時に、ロボット支援手術、内視鏡介入、経皮治療などを含む低侵襲泌尿器科技術の導入が加速し、手術の安全性、診断精度、治療効果を確保する精密泌尿器科機器の需要が大幅に増加しています。

調査対象範囲

本調査レポートは、泌尿器科機器市場を製品（機器、消耗品、付属品）、用途（腎疾患、泌尿器がん、骨盤臓器脱、良性前立腺肥大症、尿失禁、勃起不全、尿路結石、その他）、エンドユーザー（病院、ASCS（人工透析センター）およびクリニック、透析センター、在宅ケア施設）、地域（北米、欧州、アジア太平洋、ラテンアメリカ、中東およびアフリカ）別に分類しています。本レポートは、泌尿器科機器市場の成長に影響を与える主要な要因（促進要因、抑制要因、機会、課題など）に関する詳細な情報を網羅しています。主要業界プレーヤーの詳細な分析により、各社の事業概要、ソリューションとサービス、主要戦略、買収、契約に関する洞察を提供しています。また、泌尿器科機器市場に関連する新製品の発売や最近の動向についても分析しています。このレポートでは、泌尿器科機器市場のエコシステムにおける今後の新興企業の競合分析について説明します。

レポート購入の主なメリット

本レポートは、泌尿器科機器市場全体および各サブセグメントの収益数値の近似値に関する情報を提供し、市場リーダー企業および新規参入企業にとって役立ちます。また、本レポートは、市場関係者が競争環境を理解し、事業のポジショニングを改善し、適切な市場開拓戦略を策定するための洞察を深めるのに役立ちます。さらに、本レポートは、市場の動向を把握し、主要な市場牽引要因、制約要因、課題、そして機会に関する情報を提供することで、市場関係者の理解を深めるのに役立ちます。

本レポートは、以下の点について洞察を提供します。

• 泌尿器科機器市場の成長に影響を与える主要な推進要因（泌尿器疾患の発生率の上昇、低侵襲手術への関心の高まり、技術の進歩と研究開発投資の増加、病院および手術センター数の増加）、制約要因（主要プレーヤー間の統合の進展）、機会（新興国における潜在的な成長機会）、課題（主要プレーヤーによる製品リコールの増加、泌尿器科医および訓練を受けた専門家の不足）の分析
• 製品開発／イノベーション：泌尿​​器科機器市場における今後の技術、研究開発活動、新製品投入に関する詳細な洞察。
• 市場開発：収益性の高い市場に関する包括的な情報。本レポートでは、様々な地域における泌尿器科機器市場を分析しています。
• 市場多様化：泌尿器科機器市場における新製品、未開拓地域、最近の開発状況、投資に関する包括的な情報。
• 競合評価：Fresenius Medical Care AG & Co. KGaA（ドイツ）、Cardinal Health（米国）、Boston Scientific Corporation（米国）、Becton, Dickinson and Company（米国）、B. Braun Melsungen AG（ドイツ）など、泌尿器科機器市場戦略における主要企業の市場シェア、成長戦略、製品提供に関する詳細な評価。

Report Description

The global urology devices market is valued at an estimated USD 34.56 billion in 2025 and is projected to reach USD 46.26 billion by 2030, at a CAGR of 6.0% during the forecast period. The rising prevalence of chronic metabolic and cardiovascular diseases, including diabetes mellitus and hypertension, has significantly escalated the incidence of urological pathologies that necessitate prompt diagnostic assessment and surgical intervention. Immediate and evidence-based clinical management is essential to prevent disease progression and optimize patient outcomes. Concurrently, the accelerating adoption of minimally invasive urological techniques, encompassing robotic-assisted procedures, endoscopic interventions, and percutaneous therapies, has substantially increased the demand for precision urology devices that ensure procedural safety, diagnostic accuracy, and therapeutic efficacy.

The consumables & accessories segment is projected to register the fastest growth rate in the urology devices market, by product category, during the forecast period.

The urology devices market is bifurcated into instruments and consumables & accessories based on product. The consumables & accessories segment is expected to expand at a higher compound annual growth rate. The high growth rate of the consumables & accessories segment is due to increased research and development initiatives focused on developing innovative solutions for managing the rising prevalence of chronic urological diseases. Additionally, the growing emphasis on reusable consumables, device standardization, and procedural efficiency has increased demand for consumables across hospitals, surgical centers, and outpatient facilities globally.

The dialysis centers segment is projected to register the highest growth rate in the urology devices market.

Based on end users, the urology devices market is segmented into hospitals, ASCs, clinics, dialysis centers, and home care settings. Dialysis centers are experiencing the highest growth rate. This accelerated growth can be attributed to the substantially increased demand for advanced dialysis equipment and specialized facilities required for managing end-stage renal disease (ESRD). The rising prevalence of chronic kidney disease globally, coupled with the escalating incidence of diabetes and hypertension driving renal failure cases, has created urgent demand for more dialysis centers and upgraded facility infrastructure. Additionally, technological advancements in dialysis technology, improved treatment protocols, and growing patient awareness are collectively driving investment in new dialysis facilities and modern equipment, thereby propelling the dialysis centers segment to emerge as the fastest-growing end-user category in the global urology devices market.

Asia Pacific is expected to be the fastest-growing region in the global urology devices market.

The Asia Pacific region is projected to register the highest CAGR during the forecast period. This accelerated regional growth is propelled by multiple interconnected factors, including the substantially rising geriatric population requiring advanced urological interventions, escalating prevalence of kidney disease, significant disease burden from chronic kidney disease (CKD) affecting millions across the region, rapidly increasing healthcare spending and per capita income levels, growing consumer demand for therapeutic technologies, strategic expansion of private-sector hospital networks into underserved rural areas across Asia Pacific countries, and the presence of emerging high-growth markets with untapped potential. Additionally, improvements in healthcare accessibility, government initiatives supporting the development of healthcare infrastructure, and rising patient awareness of advanced urological treatment options are collectively positioning the Asia Pacific region as the most dynamic and fastest-growing market for urology devices globally.

Breakdown of supply-side primary interviews, by company type, designation, and region:

• • By Company Type: Tier 1 (40%), Tier 2 (30%), and Tier 3 (20%)
• • By Designation: C Level (27%), Director Level (18%), and Others (55%)
• • By Region: North America (51%), Europe (21%), Asia Pacific (18%), Latin America (6%), and Middle East & Africa (4%)

List of Companies Profiled in the Report

• Fresenius Medical Care AG & Co. KGaA (Germany)
• Boston Scientific Corporation (US)
• Becton, Dickinson and Company (US)
• B. Braun Melsungen AG (Germany)
• Cardinal Health (US)
• Olympus Corporation (Japan)
• Intuitive Surgical (US)
• Coloplast A/S (Denmark)
• Stryker Corporation (US)
• Teleflex Incorporated (US)
• Convatec Group PLC (UK)
• Medtronic PLC (Ireland)
• Karl Storz (Germany)
• Cook Medical (US)
• Richard Wolf GmbH (Germany)
• CompactCath (US)
• Dornier MedTech (Germany)
• Well Lead Medical Co., Ltd. (China)
• ROCAMED (Germany)
• Amniso International, Inc. (US)
• Medispec (US)
• Vimex Sp. z o.o. (Poland)
• Balton Sp. z o.o. (Poland)
• Hunter Urology (UK)
• Ribbel International Ltd. (India)

Research Coverage

This research report categorizes the urology devices market by product (instruments and consumables & accessories), application (kidney diseases, urological cancer, pelvic organ prolapse, benign prostatic hyperplasia, urinary incontinence, erectile dysfunction, urinary stones and other applications), end user (hospitals, ASCS & clinics, dialysis centers and home care settings), and region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges, influencing the growth of the urology devices market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions and services, key strategies, acquisitions, and agreements. New product launches and recent developments associated with the urology devices market. Competitive analysis of upcoming startups in the urology devices market ecosystem is covered in this report.

Key Benefits of Buying the Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall urology devices market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following pointers:

• Analysis of key drivers (Rising incidence of urological diseases, Growing preference for minimally invasive procedures, Technological advancements and increased R&D investments, Increasing number of hospitals and surgical centers) restraints (High degree of consolidation among key players), opportunities (Potential growth opportunities in emerging economies) and challenges (Increasing number of product recalls by key players, Shortage of urologists and trained professionals) influencing the growth of the urology devices market
• Product Development/Innovation: Detailed insights into upcoming technologies, research & development activities, and new product launches in the urology devices market.
• Market Development: Comprehensive information about lucrative markets – the report analyzes the urology devices market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the urology devices market
• Competitive Assessment: In-depth assessment of market shares, growth strategies and product offerings of leading players, such as Fresenius Medical Care AG & Co. KGaA (Germany), Cardinal Health (US), Boston Scientific Corporation (US), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), among others in the urology devices market strategies.

Table of Contents

1               INTRODUCTION              26

1.1           STUDY OBJECTIVES       26

1.2           MARKET DEFINITION   26

1.3           STUDY SCOPE   27

1.3.1        MARKETS COVERED       27

1.3.2        INCLUSIONS AND EXCLUSIONS 28

1.3.3        YEARS CONSIDERED      29

1.4           CURRENCY CONSIDERED            30

1.5           STAKEHOLDERS               30

1.6           SUMMARY OF CHANGES               30

2               RESEARCH METHODOLOGY       32

2.1           RESEARCH DATA              32

2.1.1        SECONDARY DATA          33

2.1.1.1    Key secondary sources         33

2.1.1.2    List of key secondary sources              33

2.1.1.3    Key data from secondary sources       34

2.1.2        PRIMARY DATA 34

2.1.2.1    Key objectives of primary research    34

2.1.2.2    List of primary sources        35

2.1.2.3    Key data from primary sources           35

2.1.2.4    Breakdown of primary interviews      36

2.1.2.5    Insights from industry experts            37

2.2           MARKET SIZE ESTIMATION         37

2.2.1        BOTTOM-UP APPROACH              37

2.2.1.1    Revenue estimation of key players     38

2.2.1.2    Annual reports and investor presentations       38

2.2.1.3    Primary interviews                38

2.2.1.4    Growth forecast    38

2.2.1.5    CAGR projections                 39

2.2.2        TOP-DOWN APPROACH                39

2.3           DATA TRIANGULATION                40

2.4           RESEARCH ASSUMPTIONS           41

2.4.1        PARAMETRIC ASSUMPTIONS     41

2.4.2        GROWTH RATE ASSUMPTIONS 41

2.4.3        SCOPE-RELATED ASSUMPTIONS              42

2.5           RESEARCH LIMITATIONS             42

2.6           RISK ANALYSIS  42

3               EXECUTIVE SUMMARY  43

4               PREMIUM INSIGHTS       47

4.1           ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN UROLOGY DEVICES MARKET     47

4.2           ASIA PACIFIC UROLOGY DEVICES MARKET, BY END USER AND COUNTRY     48

4.3           UROLOGY DEVICES MARKET, BY COUNTRY        49

4.4           UROLOGY DEVICES MARKET, BY REGION            50

5               MARKET OVERVIEW       51

5.1           INTRODUCTION              51

5.2           MARKET DYNAMICS       51

5.2.1        DRIVERS               51

5.2.1.1    Rising incidence of urological diseases              51

5.2.1.2    Growing preference for minimally invasive procedures 53

5.2.1.3    Technological advancements and increased R&D investments                 54

5.2.1.4    Increasing number of hospitals and surgical centers      55

5.2.2        RESTRAINTS      55

5.2.2.1    High degree of consolidation among key players             55

5.2.3        OPPORTUNITIES              56

5.2.3.1    Potential growth opportunities in emerging economies 56

5.2.4        CHALLENGES    57

5.2.4.1    Increasing number of product recalls by key players      57

5.2.4.2    Shortage of urologists and trained professionals             57

5.3           TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESS            58

5.4           PRICING ANALYSIS          59

5.4.1        AVERAGE SELLING PRICE TREND, BY TYPE         59

5.4.2        AVERAGE SELLING PRICE TREND, BY KEY PLAYER                 59

5.4.3        AVERAGE SELLING PRICE TREND, BY REGION   60

5.5           VALUE CHAIN ANALYSIS               61

5.6           SUPPLY CHAIN ANALYSIS             62

5.7           ECOSYSTEM ANALYSIS  63

5.8           INVESTMENT AND FUNDING SCENARIO               65

5.9           TECHNOLOGY ANALYSIS             65

5.9.1        KEY TECHNOLOGIES     65

5.9.1.1    Antimicrobial-coated catheters          65

5.9.1.2    Portable hemodialysis          66

5.9.2        COMPLEMENTARY TECHNOLOGIES       66

5.9.2.1    Smart catheters     66

5.9.2.2    Connected health & remote sensors  67

5.9.3        ADJACENT TECHNOLOGIES       67

5.9.3.1    Wearable artificial kidney   67

5.10         PATENT ANALYSIS          67

5.11         TRADE ANALYSIS             69

5.11.1      IMPORT DATA FOR HS CODE 841920       69

5.11.2      EXPORT DATA FOR HS CODE 841920       70

5.12         KEY CONFERENCES AND EVENTS, 2025–2026        70

5.13         REGULATORY ANALYSIS               71

5.13.1      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             71

5.13.2      REGULATORY FRAMEWORK       73

5.13.2.1  North America      73

5.13.2.1.1                US           73

5.13.2.1.2                Canada   73

5.13.2.2  Europe   73

5.13.2.3  Asia Pacific            73

5.13.2.3.1                China      73

5.13.2.3.2                Japan      74

5.13.2.3.3                India       74

5.13.2.4  Latin America       74

5.13.2.4.1                Brazil      74

5.13.2.4.2                Mexico   75

5.13.2.5  Middle East           75

5.13.2.6  Africa      75

5.14         PORTER’S FIVE FORCES ANALYSIS           75

5.14.1      BARGAINING POWER OF SUPPLIERS       77

5.14.2      BARGAINING POWER OF BUYERS             77

5.14.3      THREAT OF NEW ENTRANTS      77

5.14.4      THREAT OF SUBSTITUTES          78

5.14.5      INTENSITY OF COMPETITIVE RIVALRY 78

5.15         KEY STAKEHOLDERS AND BUYING CRITERIA     78

5.15.1      KEY STAKEHOLDERS IN BUYING PROCESS           79

5.15.2      KEY BUYING CRITERIA  79

5.16         IMPACT OF AI/GEN AI ON UROLOGY DEVICES MARKET                 80

5.16.1      INTRODUCTION              80

5.16.2      POTENTIAL OF AI            80

5.16.3      IMPACT OF AI   81

5.16.4      KEY COMPANIES IMPLEMENTING AI      81

5.16.5      FUTURE OF AI   82

5.17         IMPACT OF 2025 US TARIFF ON UROLOGY DEVICES MARKET               82

5.17.1      INTRODUCTION              82

5.17.2      KEY TARIFF RATES          82

5.17.3      PRICE IMPACT ANALYSIS             83

5.17.4      IMPACT ON COUNTRY/REGION                84

5.17.4.1  North America      84

5.17.4.2  Europe   84

5.17.4.3  Asia Pacific            84

5.17.5      IMPACT ON END-USE INDUSTRIES          85

5.17.5.1  Hospitals                85

5.17.5.2  Clinics    85

5.17.5.3  Ambulatory Surgical Centers (ASCs)                85

5.17.5.4  Dialysis centers     86

5.17.5.5  Home care settings               86

6               UROLOGY DEVICES MARKET, BY PRODUCT        87

6.1           INTRODUCTION              88

6.2           INSTRUMENTS 88

6.2.1        DIALYSIS DEVICES           90

6.2.1.1    Hemodialysis devices           91

6.2.1.1.1 Increasing use of dialysis machines to spur growth         91

6.2.1.2    Peritoneal dialysis devices  92

6.2.1.2.1 Rising technological advancements and increasing product approvals to propel market 92

6.2.2        ENDOSCOPES   93

6.2.2.1    Laparoscopes         94

6.2.2.1.1 Lower surgical site infections to support growth             94

6.2.2.2    Ureteroscopes       95

6.2.2.2.1 Increased usage of ureteroscopy for kidney stones to drive market                 95

6.2.2.3    Nephroscopes       97

6.2.2.3.1 High cost of maintenance to restrain market growth      97

6.2.2.4    Resectoscopes       97

6.2.2.4.1 High prevalence of prostate, kidney, and bladder cancers to fuel market    97

6.2.2.5    Cystoscopes           98

6.2.2.5.1 Growing incidence of urological cancers to boost market                 98

6.2.3        LASER & LITHOTRIPSY DEVICES               99

6.2.3.1    Associated benefits of lithotripsy devices to support growth                 99

6.2.4        ENDOVISION & IMAGING SYSTEMS         101

6.2.4.1    Need for high-resolution images to aid growth                101

6.2.5        ROBOTIC SYSTEMS         102

6.2.5.1    Growing industry-academia collaborations to fuel market                 102

6.2.6        INSUFFLATORS 103

6.2.6.1    Increasing volume of laparoscopic procedures to boost market                 103

6.2.7        ENDOSCOPY FLUID MANAGEMENT SYSTEMS    104

6.2.7.1    Growing incidence of chronic diseases to drive market 104

6.2.8        URODYNAMIC SYSTEMS               105

6.2.8.1    Rising patient pool to support growth               105

6.2.9        OTHER INSTRUMENTS 106

6.3           CONSUMABLES & ACCESSORIES                107

6.3.1        DIALYSIS CONSUMABLES             108

6.3.1.1    Growing number of dialysis procedures to fuel market  108

6.3.2        CATHETERS       109

6.3.2.1    Intermittent catheters          110

6.3.2.1.1 Rising clinical adoption of intermittent catheters to support growth    110

6.3.2.2    Indwelling catheters             112

6.3.2.2.1 Increased use in hospitals and home care settings to facilitate growth    112

6.3.2.3    External catheters 113

6.3.2.3.1 Growing preference for home-based management of chronic urinary conditions to drive market    113

6.3.3        GUIDEWIRES     114

6.3.3.1    Increasing number of surgeries and development of next-generation hybrid guidewires to drive market 114

6.3.4        RETRIEVAL DEVICES & EXTRACTORS     114

6.3.4.1    Growing number of kidney stone removal surgeries to fuel market                 114

6.3.5        SURGICAL DISSECTORS, FORCEPS & NEEDLE HOLDERS                 115

6.3.5.1    Rise in urology procedures to support growth 115

6.3.6        DILATOR SETS & URETHRAL ACCESS SHEATHS 116

6.3.6.1    Increasing demand for effective endoscopic management of ureteral and renal calculi to aid growth             116

6.3.7        STENTS & IMPLANTS     117

6.3.7.1    Growing prevalence of urological, kidney-related disorders, and erectile dysfunction to propel market                117

6.3.8        BIOPSY DEVICES              118

6.3.8.1    High incidence of prostate cancer to contribute to growth                 118

6.3.9        TUBES & DISTAL ATTACHMENTS             119

6.3.9.1    Increasing demand for endoscopy to boost market         119

6.3.10      DRAINAGE BAGS              120

6.3.10.1  Increasing prevalence of urinary incontinence and chronic kidney disease to foster growth       120

6.3.11      OTHER CONSUMABLES & ACCESSORIES                121

7               UROLOGY DEVICE MARKET, BY APPLICATION  123

7.1           INTRODUCTION              124

7.2           KIDNEY DISEASES           124

7.2.1        GROWING PREVALENCE OF DIABETES AND HYPERTENSION TO DRIVE MARKET       124

7.3           UROLOGICAL CANCER  125

7.3.1        RISING PREVALENCE OF UROLOGICAL CANCER TO CONTRIBUTE TO GROWTH         125

7.4           PELVIC ORGAN PROLAPSE          126

7.4.1        HIGH COSTS INVOLVED IN SURGERIES & HIGH REOCCURRENCE RATES TO RESTRAIN GROWTH              126

7.5           BENIGN PROSTATIC HYPERPLASIA (BPH)            127

7.5.1        INCREASING ELDERLY POPULATION TO AID GROWTH                 127

7.6           URINARY INCONTINENCE (UI)  128

7.6.1        NEED FOR PROPER DIAGNOSIS AND TREATMENT TO SUPPORT GROWTH        128

7.7           ERECTILE DYSFUNCTION            129

7.7.1        INCREASING PREVALENCE OF PROSTATE CANCER TO AID GROWTH    129

7.8           URINARY STONES            130

7.8.1        GROWING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO FUEL MARKET              130

7.9           OTHER APPLICATIONS 131

8               UROLOGY DEVICES MARKET – EPIDEMIOLOGY AND PREVALENCE ANALYSIS, 2023-2030 (NO. OF CASES/PREVALENCE)    133

9               UROLOGY DEVICES MARKET, BY END USER        134

9.1           INTRODUCTION              135

9.2           HOSPITALS         135

9.2.1        INCREASING NUMBER OF HOSPITALS IN EMERGING ECONOMIES TO EXPEDITE GROWTH     135

9.3           AMBULATORY SURGERY CENTERS          137

9.3.1        LOWER COST AND SHORTER PATIENT STAYS TO PROMOTE GROWTH      137

9.4           CLINICS                138

9.4.1        GROWING INTEGRATION OF ADVANCED TECHNOLOGY IN UROLOGY CLINICS TO PROPEL MARKET                 138

9.5           DIALYSIS CENTERS          139

9.5.1        RISING DEMAND FOR ADVANCED DIALYSIS AND END-STAGE RENAL DISEASE TREATMENTS TO AID GROWTH                 139

9.6           HOME CARE SETTINGS 140

9.6.1        LOWER COST AND SHORTER HOSPITAL STAYS TO BOOST MARKET               140

10            UROLOGY DEVICES MARKET, BY REGION            142

10.1         INTRODUCTION              143

10.2         NORTH AMERICA             143

10.2.1      MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 144

10.2.2      US           147

10.2.2.1  Presence of large dialysis patient base and robust infrastructure to promote growth                147

10.2.3      CANADA               151

10.2.3.1  Increasing focus on preventing target diseases to expedite growth                 151

10.3         EUROPE               154

10.3.1      MACROECONOMIC OUTLOOK FOR EUROPE      155

10.3.2      GERMANY           157

10.3.2.1  Presence of major urology device manufacturers to contribute to growth    157

10.3.3      UK          161

10.3.3.1  Rising incidence of kidney conditions to bolster growth                 161

10.3.4      FRANCE                164

10.3.4.1  Favorable government initiatives and shifting demographic trends to aid growth             164

10.3.5      ITALY    167

10.3.5.1  Increasing cases of chronic diseases to spur growth        167

10.3.6      SPAIN    170

10.3.6.1  Rising geriatric population to accelerate growth              170

10.3.7      REST OF EUROPE             173

10.4         ASIA PACIFIC     176

10.4.1      MACROECONOMIC OUTLOOK  177

10.4.2      CHINA  179

10.4.2.1  Rising incidence of target health conditions and decreasing mortality rate to facilitate growth      179

10.4.3      JAPAN   182

10.4.3.1  Large geriatric population and established healthcare system to support growth      182

10.4.4      INDIA    185

10.4.4.1  Large patient pool and rapidly growing healthcare sector to drive market    185

10.4.5      REST OF ASIA PACIFIC   189

10.5         LATIN AMERICA                192

10.5.1      MACROECONOMIC OUTLOOK  192

10.5.2      BRAZIL 194

10.5.2.1  Rising cases of metabolic diseases to support growth     194

10.5.3      MEXICO                197

10.5.3.1  Increasing prevalence of diabetes and kidney disorders to expedite growth    197

10.5.4      REST OF LATIN AMERICA             200

10.6         MIDDLE EAST & AFRICA                203

10.6.1      MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 204

11            COMPETITIVE LANDSCAPE         206

11.1         OVERVIEW          206

11.2         KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022–2025                 206

11.3         REVENUE ANALYSIS, 2022–2024  207

11.4         MARKET SHARE ANALYSIS, 2024                 208

11.5         COMPANY VALUATION AND FINANCIAL METRICS                 211

11.6         BRAND/PRODUCT COMPARISON             212

11.7         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 213

11.7.1      STARS   213

11.7.2      EMERGING LEADERS     213

11.7.3      PERVASIVE PLAYERS      213

11.7.4      PARTICIPANTS 213

11.7.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         214

11.7.5.1  Company footprint               214

11.7.5.2  Region footprint   215

11.7.5.3  Product footprint  215

11.8         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024        215

11.8.1      PROGRESSIVE COMPANIES         215

11.8.2      RESPONSIVE COMPANIES            216

11.8.3      DYNAMIC COMPANIES  216

11.8.4      STARTING BLOCKS         216

11.8.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024                 217

11.8.5.1  Detailed list of key startups/SMEs    217

11.8.5.2  Competitive benchmarking of key startups/SMEs          217

11.9         COMPETITIVE SCENARIO             217

11.9.1      PRODUCT LAUNCHES AND APPROVALS               217

11.9.2      DEALS  219

11.9.3      EXPANSIONS     220

12            COMPANY PROFILES      221

12.1         KEY PLAYERS     221

12.1.1      FRESENIUS MEDICAL CARE AG & CO. KGAA         221

12.1.1.1  Business overview 221

12.1.1.2  Products offered   222

12.1.1.3  Recent developments           223

12.1.1.3.1                Deals      223

12.1.1.3.2                Expansions             223

12.1.1.4  MnM view              223

12.1.1.4.1                Key strengths        223

12.1.1.4.2                Strategic choices   223

12.1.1.4.3                Weaknesses and competitive threats 224

12.1.2      BOSTON SCIENTIFIC CORPORATION     225

12.1.2.1  Business overview 225

12.1.2.2  Products offered   226

12.1.2.3  Recent developments           228

12.1.2.3.1                Product launches and approvals         228

12.1.2.3.2                Deals      229

12.1.2.4  MnM view              229

12.1.2.4.1                Key strengths        229

12.1.2.4.2                Strategic choices   229

12.1.2.4.3                Weaknesses and competitive threats 229

12.1.3      B. BRAUN MELSUNGEN AG          230

12.1.3.1  Business overview 230

12.1.3.2  Products offered   231

12.1.3.3  Recent developments           233

12.1.3.3.1                Deals      233

12.1.3.4  MnM view              233

12.1.3.4.1                Key strengths        233

12.1.3.4.2                Strategic choices   233

12.1.3.4.3                Weaknesses and competitive threats 233

12.1.4      BECTON, DICKINSON AND COMPANY   234

12.1.4.1  Business overview 234

12.1.4.2  Products offered   235

12.1.4.3  MnM view              238

12.1.4.3.1                Key strengths        238

12.1.4.3.2                Strategic choices   238

12.1.4.3.3                Weaknesses and competitive threats 238

12.1.5      OLYMPUS CORPORATION           239

12.1.5.1  Business overview 239

12.1.5.2  Products offered   240

12.1.5.3  Recent developments           243

12.1.5.3.1                Product launches and approvals         243

12.1.5.3.2                Deals      243

12.1.5.3.3                Expansions             243

12.1.6      CARDINAL HEALTH        244

12.1.6.1  Business overview 244

12.1.6.2  Products offered   245

12.1.6.3  Recent developments           246

12.1.6.3.1                Deals      246

12.1.7      INTUITIVE SURGICAL    247

12.1.7.1  Business overview 247

12.1.7.2  Products offered   248

12.1.7.3  Recent developments           249

12.1.7.3.1                Product launches and approvals         249

12.1.8      COLOPLAST A/S               250

12.1.8.1  Business overview 250

12.1.8.2  Products offered   251

12.1.8.3  Recent developments           253

12.1.8.3.1                Product launches and approvals         253

12.1.9      STRYKER              254

12.1.9.1  Business overview 254

12.1.9.2  Products offered   255

12.1.9.3  Recent developments           256

12.1.9.3.1                Product launches and approvals         256

12.1.10   TELEFLEX INCORPORATED        257

12.1.10.1                 Business overview 257

12.1.10.2                 Products offered   258

12.1.10.3                 Recent developments           261

12.1.10.3.1             Product launches and approvals         261

12.1.11   CONVATEC GROUP PLC                262

12.1.11.1                 Business overview 262

12.1.11.2                 Products offered   263

12.1.12   MEDTRONIC PLC             264

12.1.12.1                 Business overview 264

12.1.12.2                 Products offered   265

12.1.12.3                 Recent developments           266

12.1.12.3.1             Expansions             266

12.2         OTHER PLAYERS              267

12.2.1      KARL STORZ      267

12.2.2      COOK MEDICAL                268

12.2.3      RICHARD WOLF GMBH 271

12.2.4      COMPACTCATH                272

12.2.5      DORNIER MEDTECH      273

12.2.6      NIKKISO CO., LTD.           274

12.2.7      DIALIFE SA          275

12.2.8      ERBE VISION      276

12.2.9      WELL LEAD MEDICAL CO., LTD.                277

12.2.10   ROCAMED           278

12.2.11   ENDOMED SYSTEMS GMBH        279

12.2.12   AMSINO INTERNATIONAL, INC.                 280

12.2.13   MEDISPEC           281

12.2.14   VIMEX SP. Z O. O.             282

12.2.15   BALTON SP. Z O.O.          283

12.2.16   HUNTER UROLOGY        284

12.2.17   RIBBEL INTERNATIONAL LIMITED          285

13            APPENDIX           286

13.1         DISCUSSION GUIDE        286

13.2         KNOWLEDGESTORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL                289

13.3         CUSTOMIZATION OPTIONS        291

13.4         RELATED REPORTS         291

13.5         AUTHOR DETAILS           292

LIST OF TABLES

TABLE 1                UROLOGY DEVICES MARKET: SCOPE-RELATED ASSUMPTIONS  42

TABLE 2                UROLOGY DEVICES MARKET: RISK ANALYSIS                 42

TABLE 3                GLOBAL INCIDENCE OF UROLOGICAL CANCER, 2022        52

TABLE 4                LIST OF PRODUCT RECALLS BY KEY PLAYERS, 2022–2023              57

TABLE 5                AVERAGE SELLING PRICING TREND OF UROLOGY DEVICES, BY TYPE,

2023–2025 (USD)                59

TABLE 6                AVERAGE SELLING PRICE TREND OF UROLOGY DEVICES, BY KEY PLAYER,

2023–2025 (USD)                60

TABLE 7                AVERAGE SELLING PRICE TREND OF UROLOGY DEVICES PRODUCTS, BY REGION,  2023–2025 (USD)       60

TABLE 8                UROLOGY DEVICES MARKET: ROLE OF KEY PLAYERS IN ECOSYSTEM              64

TABLE 9                KEY PATENTS IN UROLOGY DEVICES MARKET, 2022–2025              68

TABLE 10              IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020–2024 (USD MILLION)     69

TABLE 11              EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020–2024 (USD MILLION)     70

TABLE 12              UROLOGY DEVICES MARKET: KEY CONFERENCES AND EVENTS,

JANUARY 2025–DECEMBER 2026 70

TABLE 13              NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 71

TABLE 14              EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS           72

TABLE 15              ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 72

TABLE 16              LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 72

TABLE 17              UROLOGY DEVICES MARKET: IMPACT OF PORTER’S FIVE FORCES 76

TABLE 18              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE

END USERS (%) 79

TABLE 19              KEY BUYING CRITERIA FOR TOP THREE END USERS   80

TABLE 20              KEY COMPANIES IMPLEMENTING AI IN UROLOGY DEVICES MARKET     81

TABLE 21              US ADJUSTED RECIPROCAL TARIFF RATES                 82

TABLE 22              UROLOGY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            88

TABLE 23              UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY REGION,

2023–2030 (USD MILLION)            89

TABLE 24              UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE,

2023–2030 (USD MILLION)            89

TABLE 25              UROLOGY DEVICES MARKET FOR DIALYSIS DEVICES, BY REGION,

2023–2030 (USD MILLION)            90

TABLE 26              UROLOGY DEVICES MARKET FOR DIALYSIS DEVICES, BY TYPE,

2023–2030 (USD MILLION)            91

TABLE 27              UROLOGY DEVICES MARKET FOR HEMODIALYSIS DEVICES, BY REGION,

2023–2030 (USD MILLION)            92

TABLE 28              UROLOGY DEVICES MARKET FOR PERITONEAL DIALYSIS DEVICES, BY REGION,  2023–2030 (USD MILLION)                 93

TABLE 29             UROLOGY DEVICES MARKET FOR ENDOSCOPES, BY REGION,

2023–2030 (USD MILLION)            94

TABLE 30             UROLOGY DEVICES MARKET FOR ENDOSCOPES, BY TYPE,

2023–2030 (USD MILLION)            94

TABLE 31              UROLOGY DEVICES MARKET FOR LAPAROSCOPES, BY REGION,

2023–2030 (USD MILLION)            95

TABLE 32              UROLOGY DEVICES MARKET FOR URETEROSCOPES, BY REGION,

2023–2030 (USD MILLION)            96

TABLE 33              UROLOGY DEVICES MARKET FOR NEPHROSCOPES, BY REGION,

2023–2030 (USD MILLION)            97

TABLE 34              UROLOGY DEVICES MARKET FOR RESECTOSCOPES, BY REGION,

2023–2030 (USD MILLION)            98

TABLE 35              UROLOGY DEVICES MARKET FOR CYSTOSCOPES, BY REGION,

2023–2030 (USD MILLION)            99

TABLE 36              UROLOGY DEVICES MARKET FOR LASER & LITHOTRIPSY DEVICES, BY REGION,  2023–2030 (USD MILLION)                 100

TABLE 37              UROLOGY DEVICES MARKET FOR ENDOVISION & IMAGING SYSTEMS, BY REGION,  2023–2030 (USD MILLION)                 102

TABLE 38              UROLOGY DEVICES MARKET FOR ROBOTIC SYSTEMS, BY REGION,

2023–2030 (USD MILLION)            103

TABLE 39              UROLOGY DEVICES MARKET FOR INSUFFLATORS, BY REGION,

2023–2030 (USD MILLION)            104

TABLE 40              UROLOGY DEVICES MARKET FOR ENDOSCOPY FLUID MANAGEMENT SYSTEMS,

BY REGION, 2023–2030 (USD MILLION)   105

TABLE 41              UROLOGY DEVICES MARKET FOR URODYNAMIC SYSTEMS, BY REGION,

2023–2030 (USD MILLION)            106

TABLE 42              UROLOGY DEVICES MARKET FOR OTHER INSTRUMENTS, BY REGION,

2023–2030 (USD MILLION)            107

TABLE 43              UROLOGY DEVICES MARKET FOR CONSUMABLES & ACCESSORIES, BY REGION,  2023–2030 (USD MILLION)            107

TABLE 44              UROLOGY DEVICES MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE,  2023–2030 (USD MILLION)            108

TABLE 45              UROLOGY DEVICES MARKET FOR DIALYSIS CONSUMABLES, BY REGION,

2023–2030 (USD MILLION)            109

TABLE 46              UROLOGY DEVICES MARKET FOR CATHETERS, BY REGION,

2023–2030 (USD MILLION)            110

TABLE 47              UROLOGY DEVICES MARKET FOR CATHETERS, BY TYPE,

2023–2030 (USD MILLION)            110

TABLE 48              UROLOGY DEVICES MARKET FOR INTERMITTENT CATHETERS, BY REGION,

2023–2030 (USD MILLION)            111

TABLE 49              UROLOGY DEVICES MARKET FOR INDWELLING CATHETERS, BY REGION,

2023–2030 (USD MILLION)            112

TABLE 50              UROLOGY DEVICES MARKET FOR EXTERNAL CATHETERS, BY REGION,

2023–2030 (USD MILLION)            113

TABLE 51              UROLOGY DEVICES MARKET FOR GUIDEWIRES, BY REGION,

2023–2030 (USD MILLION)            114

TABLE 52              UROLOGY DEVICES MARKET FOR RETRIEVAL DEVICES & EXTRACTORS, BY REGION,  2023–2030 (USD MILLION)            115

TABLE 53              UROLOGY DEVICES MARKET FOR SURGICAL DISSECTORS, FORCEPS & NEEDLE HOLDERS, BY REGION, 2023–2030 (USD MILLION)       116

TABLE 54              UROLOGY DEVICES MARKET FOR DILATOR SETS & URETHRAL ACCESS SHEATHS,  BY REGION, 2023–2030 (USD MILLION) 117

TABLE 55              UROLOGY DEVICES MARKET FOR STENTS & IMPLANTS, BY REGION,

2023–2030 (USD MILLION              118

TABLE 56              UROLOGY DEVICES MARKET FOR BIOPSY DEVICES, BY REGION,

2023–2030 (USD MILLION)            119

TABLE 57              UROLOGY DEVICES MARKET FOR TUBES & DISTAL ATTACHMENTS, BY REGION,  2023–2030 (USD MILLION)            120

TABLE 58              UROLOGY DEVICES MARKET FOR DRAINAGE BAGS, BY REGION,

2023–2030 (USD MILLION)            121

TABLE 59              UROLOGY DEVICES MARKET FOR OTHER CONSUMABLES & ACCESSORIES,

BY REGION, 2023–2030 (USD MILLION)   122

TABLE 60              UROLOGY DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            124

TABLE 61              UROLOGY DEVICES MARKET FOR KIDNEY DISEASES, BY REGION,

2023–2030 (USD MILLION)            125

TABLE 62              UROLOGY DEVICES MARKET FOR UROLOGICAL CANCER, BY REGION,

2023–2030 (USD MILLION)            126

TABLE 63              UROLOGY DEVICES MARKET FOR PELVIC ORGAN PROLAPSE, BY REGION,

2023–2030 (USD MILLION)            127

TABLE 64              UROLOGY DEVICES MARKET FOR BENIGN PROSTATIC HYPERPLASIA (BPH),

BY REGION, 2023–2030 (USD MILLION)   128

TABLE 65              UROLOGY DEVICES MARKET FOR BENIGN URINARY INCONTINENCE (UI),

BY REGION, 2023–2030 (USD MILLION)   129

TABLE 66              UROLOGY DEVICES MARKET FOR ERECTILE DYSFUNCTION, BY REGION,

2023–2030 (USD MILLION)            130

TABLE 67              UROLOGY DEVICES MARKET FOR URINARY STONES, BY REGION,

2023–2030 (USD MILLION)            131

TABLE 68              UROLOGY DEVICES MARKET FOR OTHER APPLICATIONS, BY REGION,

2023–2030 (USD MILLION)            132

TABLE 69              UROLOGY DEVICES MARKET: PREVALENCE OF EPIDEMIOLOGY, BY APPLICATION, 2023–2030     133

TABLE 70              UROLOGY DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)            135

TABLE 71              UROLOGY DEVICES MARKET FOR HOSPITALS, BY REGION,

2023–2030 (USD MILLION)            136

TABLE 72              UROLOGY DEVICES MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION,  2023–2030 (USD MILLION) 138

TABLE 73              UROLOGY DEVICES MARKET FOR CLINICS, BY REGION, 2023–2030 (USD MILLION)          139

TABLE 74              UROLOGY DEVICES MARKET FOR DIALYSIS CENTERS, BY REGION,

2023–2030 (USD MILLION)            140

TABLE 75              UROLOGY DEVICES MARKET FOR HOME CARE SETTINGS, BY REGION,

2023–2030 (USD MILLION)            141

TABLE 76              UROLOGY DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION)       143

TABLE 77              NORTH AMERICA: KEY MACROECONOMIC INDICATORS      144

TABLE 78              NORTH AMERICA: UROLOGY DEVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            145

TABLE 79              NORTH AMERICA: UROLOGY DEVICES MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            146

TABLE 80              NORTH AMERICA: UROLOGY DEVICES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            146

TABLE 81              NORTH AMERICA: UROLOGY DEVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            147

TABLE 82              US: UROLOGY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            148

TABLE 83              US: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE,

2023–2030 (USD MILLION)            149

TABLE 84              US: UROLOGY DEVICES MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE,  2023–2030 (USD MILLION)            150

TABLE 85              US: UROLOGY DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              150

TABLE 86              US: UROLOGY DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)            151

TABLE 87              CANADA: UROLOGY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     152

TABLE 88              CANADA: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE,

2023–2030 (USD MILLION)            152

TABLE 89              CANADA: UROLOGY DEVICES MARKET FOR CONSUMABLES & ACCESSORIES,

BY TYPE, 2023–2030 (USD MILLION)         153

TABLE 90              CANADA: UROLOGY DEVICES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            153

TABLE 91              CANADA: UROLOGY DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)                154

TABLE 92              EUROPE: KEY MACROECONOMIC INDICATORS                 155

TABLE 93              EUROPE: UROLOGY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     156

TABLE 94              EUROPE: UROLOGY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     156

TABLE 95              EUROPE: UROLOGY DEVICES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            157

TABLE 96              EUROPE: UROLOGY DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)                157

TABLE 97              GERMANY: UROLOGY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     158

TABLE 98              GERMANY: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE,

2023–2030 (USD MILLION)            159

TABLE 99              GERMANY: UROLOGY DEVICES MARKET FOR CONSUMABLES & ACCESSORIES,

BY TYPE, 2023–2030 (USD MILLION)         160

TABLE 100            GERMANY: UROLOGY DEVICES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            160

TABLE 101            GERMANY: UROLOGY DEVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            161

TABLE 102            UK: UROLOGY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            162

TABLE 103            UK: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE,

2023–2030 (USD MILLION)            162

TABLE 104            UK: UROLOGY DEVICES MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE,  2023–2030 (USD MILLION)            163

TABLE 105            UK: UROLOGY DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              163

TABLE 106            UK: UROLOGY DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)            164

TABLE 107            FRANCE: UROLOGY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     165

TABLE 108            FRANCE: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE,

2023–2030 (USD MILLION)            165

TABLE 109            FRANCE: UROLOGY DEVICES MARKET FOR CONSUMABLES & ACCESSORIES,

BY TYPE, 2023–2030 (USD MILLION)         166

TABLE 110            FRANCE: UROLOGY DEVICES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            166

TABLE 111            FRANCE: UROLOGY DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)                167

TABLE 112            ITALY: UROLOGY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     168

TABLE 113            ITALY: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE,

2023–2030 (USD MILLION)            168

TABLE 114            ITALY: UROLOGY DEVICES MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION)            169

TABLE 115            ITALY: UROLOGY DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              169

TABLE 116            ITALY: UROLOGY DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)                170

TABLE 117            SPAIN: UROLOGY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     171

TABLE 118            SPAIN: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE,

2023–2030 (USD MILLION)            171

TABLE 119            SPAIN: UROLOGY DEVICES MARKET FOR CONSUMABLES & ACCESSORIES,

BY TYPE, 2023–2030 (USD MILLION)         172

TABLE 120            SPAIN: UROLOGY DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              172

TABLE 121            SPAIN: UROLOGY DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)                173

TABLE 122            REST OF EUROPE: UROLOGY DEVICES MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            174

TABLE 123            REST OF EUROPE: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE,  2023–2030 (USD MILLION)                 174

TABLE 124            REST OF EUROPE: UROLOGY DEVICES MARKET FOR CONSUMABLES & ACCESSORIES,  BY TYPE, 2023–2030 (USD MILLION)            175

TABLE 125            REST OF EUROPE: UROLOGY DEVICES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            175

TABLE 126            REST OF EUROPE: UROLOGY DEVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            176

TABLE 127            ASIA PACIFIC: KEY MACROECONOMIC INDICATORS      177

TABLE 128            ASIA PACIFIC: UROLOGY DEVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            178

TABLE 129            ASIA PACIFIC: UROLOGY DEVICES MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            178

TABLE 130            ASIA PACIFIC: UROLOGY DEVICES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            178

TABLE 131            ASIA PACIFIC: UROLOGY DEVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            179

TABLE 132            CHINA: UROLOGY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     180

TABLE 133            CHINA: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE,

2023–2030 (USD MILLION)            180

TABLE 134            CHINA: UROLOGY DEVICES MARKET FOR CONSUMABLES & ACCESSORIES,

BY TYPE, 2023–2030 (USD MILLION)         181

TABLE 135            CHINA: UROLOGY DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              181

TABLE 136            CHINA: UROLOGY DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)                182

TABLE 137            JAPAN: UROLOGY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     183

TABLE 138            JAPAN: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE,

2023–2030 (USD MILLION)            183

TABLE 139            JAPAN: UROLOGY DEVICES MARKET FOR CONSUMABLES & ACCESSORIES,

BY TYPE, 2023–2030 (USD MILLION)         184

TABLE 140            JAPAN: UROLOGY DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              184

TABLE 141            JAPAN: UROLOGY DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)                185

TABLE 142            INDIA: UROLOGY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     186

TABLE 143            INDIA: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE,

2023–2030 (USD MILLION)            187

TABLE 144            INDIA: UROLOGY DEVICES MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION)            188

TABLE 145            INDIA: UROLOGY DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              188

TABLE 146            INDIA: UROLOGY DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)                189

TABLE 147            REST OF ASIA PACIFIC: UROLOGY DEVICES MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            190

TABLE 148            REST OF ASIA PACIFIC: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE,  2023–2030 (USD MILLION)            190

TABLE 149            REST OF ASIA PACIFIC: UROLOGY DEVICES MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION)       191

TABLE 150            REST OF ASIA PACIFIC: UROLOGY DEVICES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            191

TABLE 151            REST OF ASIA PACIFIC: UROLOGY DEVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            192

TABLE 152            LATIN AMERICA: KEY MACROECONOMIC INDICATORS      192

TABLE 153            LATIN AMERICA: UROLOGY DEVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            193

TABLE 154            LATIN AMERICA: UROLOGY DEVICES MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            193

TABLE 155            LATIN AMERICA: UROLOGY DEVICES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            194

TABLE 156            LATIN AMERICA: UROLOGY DEVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            194

TABLE 157            BRAZIL: UROLOGY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     195

TABLE 158            BRAZIL: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE,

2023–2030 (USD MILLION)            195

TABLE 159            BRAZIL: UROLOGY DEVICES MARKET FOR CONSUMABLES & ACCESSORIES,

BY TYPE, 2023–2030 (USD MILLION)         196

TABLE 160            BRAZIL: UROLOGY DEVICES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            196

TABLE 161            BRAZIL: UROLOGY DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)                197

TABLE 162            MEXICO: UROLOGY DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     198

TABLE 163            MEXICO: UROLOGY DEVICES MARKET FOR INSTRUMENTS, BY TYPE,

2023–2030 (USD MILLION)            198

TABLE 164            MEXICO: UROLOGY DEVICES MARKET FOR CONSUMABLES & ACCESSORIES,

BY TYPE, 2023–2030 (USD MILLION)         199

TABLE 165            MEXICO: UROLOGY DEVICES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            199

TABLE 166            MEXICO: UROLOGY DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)                200

TABLE 167            REST OF LATIN AMERICA: UROLOGY DEVICES MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            200

TABLE 168            REST OF LATIN AMERICA: UROLOGY DEVICES MARKET FOR INSTRUMENTS,

BY TYPE, 2023–2030 (USD MILLION)         201

TABLE 169            REST OF LATIN AMERICA: UROLOGY DEVICES MARKET FOR CONSUMABLES & ACCESSORIES, BY TYPE, 2023–2030 (USD MILLION)       202

TABLE 170            REST OF LATIN AMERICA: UROLOGY DEVICES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            202

TABLE 171            REST OF LATIN AMERICA: UROLOGY DEVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            203

TABLE 172            MIDDLE EAST & AFRICA: KEY MACROECONOMIC INDICATORS              204

TABLE 173            MIDDLE EAST & AFRICA: UROLOGY DEVICES MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            204

TABLE 174            MIDDLE EAST & AFRICA: UROLOGY DEVICES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            205

TABLE 175            MIDDLE EAST & AFRICA: UROLOGY DEVICES MARKET, BY END USER,

2023–2030 (USD MILLION)            205

TABLE 176            UROLOGY DEVICES MARKET: KEY PLAYER STRATEGIES/RIGHT TO WIN,

2022–2025              206

TABLE 177            UROLOGY DEVICES MARKET: DEGREE OF COMPETITION 209

TABLE 178            UROLOGY DEVICES MARKET: REGION FOOTPRINT       215

TABLE 179            UROLOGY DEVICES MARKET: PRODUCT FOOTPRINT       215

TABLE 180            UROLOGY DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES              217

TABLE 181            UROLOGY DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES          217

TABLE 182            UROLOGY DEVICES MARKET: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2022–NOVEMBER 2025                 218

TABLE 183            UROLOGY DEVICES MARKET: DEALS, JANUARY 2022–NOVEMBER 2025    219

TABLE 184            UROLOGY DEVICES MARKET: EXPANSIONS, JANUARY 2022–NOVEMBER 2025                 220

TABLE 185            FRESENIUS MEDICAL CARE AG & CO. KGAA: COMPANY OVERVIEW   221

TABLE 186            FRESENIUS MEDICAL CARE AG & CO. KGAA: PRODUCTS OFFERED    222

TABLE 187            FRESENIUS MEDICAL CARE AG & CO. KGAA: DEALS,

JANUARY 2022–NOVEMBER 2025                 223

TABLE 188            FRESENIUS MEDICAL CARE AG & CO. KGAA: EXPANSIONS,

JANUARY 2022–NOVEMBER 2025                 223

TABLE 189            BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW   225

TABLE 190            BOSON SCIENTIFIC CORPORATION: PRODUCTS OFFERED             226

TABLE 191            BOSON SCIENTIFIC CORPORATION: PRODUCT LAUNCHES AND APPROVALS,  JANUARY 2022–NOVEMBER 2025                 228

TABLE 192            BOSON SCIENTIFIC CORPORATION: DEALS, JANUARY 2022–NOVEMBER 2025                 229

TABLE 193            B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW          230

TABLE 194            B. BRAUN MELSUNGEN AG: PRODUCTS OFFERED             231

TABLE 195            B. BRAUN MELSUNGEN AG: DEALS, JANUARY 2022–NOVEMBER 2025    233

TABLE 196            BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW   234

TABLE 197            BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED    235

TABLE 198            OLYMPUS CORPORATION: COMPANY OVERVIEW          239

TABLE 199            OLYMPUS CORPORATION: PRODUCTS OFFERED             240

TABLE 200            OLYMPUS CORPORATION: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2022–NOVEMBER 2025                 243

TABLE 201            OLYMPUS CORPORATION: DEALS, JANUARY 2022–NOVEMBER 2025    243

TABLE 202            OLYMPUS CORPORATION: EXPANSIONS, JANUARY 2022–NOVEMBER 2025                 243

TABLE 203            CARDINAL HEALTH: COMPANY OVERVIEW                 244

TABLE 204            CARDINAL HEALTH: PRODUCTS OFFERED                 245

TABLE 205            CARDINAL HEALTH: DEALS, JANUARY 2022–NOVEMBER 2025               246

TABLE 206            INTUITIVE SURGICAL: COMPANY OVERVIEW                 247

TABLE 207            INTUITIVE SURGICAL: PRODUCTS OFFERED                 248

TABLE 208            INTUITIVE SURGICAL: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2022–NOVEMBER 2025                 249

TABLE 209            COLOPLAST A/S: COMPANY OVERVIEW                 250

TABLE 210            COLOPLAST A/S: PRODUCTS OFFERED 251

TABLE 211            COLOPLAST A/S: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2022–NOVEMBER 2025                 253

TABLE 212            STRYKER: COMPANY OVERVIEW               254

TABLE 213            STRYKER: PRODUCTS OFFERED                255

TABLE 214            STRYKER: PRODUCT LAUNCHES AND APPROVALS,

JANUARY 2022–NOVEMBER 2025                 256

TABLE 215            TELEFLEX INCORPORATED: COMPANY OVERVIEW          257

TABLE 216            TELEFLEX INCORPORATED: PRODUCTS OFFERED             258

TABLE 217            TELEFLEX INCORPORATED: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–NOVEMBER 2025                 261

TABLE 218            CONVATEC GROUP PLC: COMPANY OVERVIEW                 262

TABLE 219            CONVATEC GROUP PLC: PRODUCTS OFFERED                 263

TABLE 220            MEDTRONIC PLC: COMPANY OVERVIEW                 264

TABLE 221            MEDTRONIC PLC: PRODUCTS OFFERED                 265

TABLE 222            MEDTRONIC PLC: EXPANSIONS, JANUARY 2022–NOVEMBER 2025               266

TABLE 223            KARL STORZ: COMPANY OVERVIEW       267

TABLE 224            COOK MEDICAL: COMPANY OVERVIEW                 268

TABLE 225            RICHARD WOLF GMBH: COMPANY OVERVIEW                 271

TABLE 226            COMPACTCATH: COMPANY OVERVIEW                 272

TABLE 227            DORNIER MEDTECH: COMPANY OVERVIEW                 273

TABLE 228            NIKKISO CO., LTD.: COMPANY OVERVIEW                 274

TABLE 229            DIALIFE SA: COMPANY OVERVIEW          275

TABLE 230            ERBE VISION: COMPANY OVERVIEW       276

TABLE 231            WELL LEAD MEDICAL CO., LTD.: COMPANY OVERVIEW          277

TABLE 232            ROCAMED: COMPANY OVERVIEW            278

TABLE 233            ENDOMED SYSTEMS GMBH: COMPANY OVERVIEW          279

TABLE 234            AMSINO INTERNATIONAL, INC.: COMPANY OVERVIEW          280

TABLE 235            MEDISPEC: COMPANY OVERVIEW            281

TABLE 236            VIMEX SP. Z O.O.: COMPANY OVERVIEW                 282

TABLE 237            BALTON SP. Z O.O.: COMPANY OVERVIEW                 283

TABLE 238            HUNTER UROLOGY: COMPANY OVERVIEW                 284

TABLE 239            RIBBEL INTERNATIONAL LIMITED: COMPANY OVERVIEW          285

LIST OF FIGURES

FIGURE 1              UROLOGY DEVICES MARKET SEGMENTATION AND REGIONS COVERED              27

FIGURE 2              UROLOGY DEVICES MARKET: RESEARCH DESIGN                32

FIGURE 3              UROLOGY DEVICES MARKET: KEY DATA FROM SECONDARY SOURCES  34

FIGURE 4              LIST OF PRIMARY SOURCES IN UROLOGY DEVICES MARKET            35

FIGURE 5              BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION  36

FIGURE 6              UROLOGY DEVICES MARKET: KEY INSIGHTS FROM PRIMARY EXPERTS             37

FIGURE 7              REVENUE ESTIMATION OF KEY PLAYERS IN UROLOGY DEVICES MARKET     38

FIGURE 8              UROLOGY DEVICES MARKET: CAGR PROJECTIONS   39

FIGURE 9              UROLOGY DEVICES MARKET: TOP-DOWN APPROACH         39

FIGURE 10            UROLOGY DEVICES MARKET: DATA TRIANGULATION             40

FIGURE 11            UROLOGY DEVICES MARKET: PARAMETRIC ASSUMPTIONS  41

FIGURE 12            UROLOGY DEVICES MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)      43

FIGURE 13            UROLOGY DEVICES MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)      44

FIGURE 14            UROLOGY DEVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)      45

FIGURE 15            GEOGRAPHICAL SNAPSHOT OF UROLOGY DEVICES MARKET            46

FIGURE 16            GROWING PREVALENCE OF UROLOGICAL DISEASES AND PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO DRIVE MARKET            47

FIGURE 17            HOSPITALS SEGMENT AND CHINA LED ASIA PACIFIC MARKET IN 2024              48

FIGURE 18            CHINA TO BE FASTEST-GROWING MARKET DURING FORECAST PERIOD       49

FIGURE 19            ASIA PACIFIC TO EXHIBIT FASTEST GROWTH DURING FORECAST PERIOD       50

FIGURE 20            UROLOGY DEVICES MARKET DYNAMICS: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES                 51

FIGURE 21            CANADA: NUMBER OF TOTAL INCIDENTS OF END-STAGE RENAL DISEASE PATIENTS, BY AGE GROUP, 2022                 53

FIGURE 22            TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS IN UROLOGY DEVICES MARKET                 58

FIGURE 23            UROLOGY DEVICES MARKET: VALUE CHAIN ANALYSIS            61

FIGURE 24            UROLOGY DEVICES MARKET: SUPPLY CHAIN ANALYSIS            62

FIGURE 25            UROLOGY DEVICES MARKET: ECOSYSTEM ANALYSIS            64

FIGURE 26            UROLOGY DEVICES MARKET: FUNDING AND NUMBER OF DEALS,

2020–2025 (USD MILLION)            65

FIGURE 27            UROLOGY DEVICES MARKET: PATENT ANALYSIS, 2015–2024       68

FIGURE 28            UROLOGY DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS           76

FIGURE 29            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR  TOP THREE END USERS                79

FIGURE 30            KEY BUYING CRITERIA FOR TOP THREE END USERS   79

FIGURE 31            IMPACT OF AI ON UROLOGY DEVICES MARKET                 81

FIGURE 32            NORTH AMERICA: UROLOGY DEVICES MARKET SNAPSHOT          145

FIGURE 33            ASIA PACIFIC: UROLOGY DEVICES MARKET SNAPSHOT          177

FIGURE 34            REVENUE ANALYSIS OF KEY PLAYERS, 2022–2024 (USD MILLION) 207

FIGURE 35            MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024        208

FIGURE 36            US: MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024        210

FIGURE 37            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND FIVE-YEAR STOCK BETA OF

KEY VENDORS  211

FIGURE 38            EV/EBITDA OF KEY VENDORS   212

FIGURE 39            UROLOGY DEVICES MARKET: BRAND/PRODUCT COMPARISON             212

FIGURE 40            UROLOGY DEVICES MARKET: COMPANY EVALUATION MATRIX

(KEY PLAYERS), 2024       214

FIGURE 41            UROLOGY DEVICES MARKET: COMPANY FOOTPRINT       214

FIGURE 42            UROLOGY DEVICES MARKET: COMPANY EVALUATION MATRIX

(STARTUPS/SMES), 2024                216

FIGURE 43            FRESENIUS MEDICAL CARE AG & CO. KGAA: COMPANY SNAPSHOT (2024)      222

FIGURE 44            BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2024)      226

FIGURE 45            B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2024)             231

FIGURE 46            BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2024)      235

FIGURE 47            OLYMPUS CORPORATION: COMPANY SNAPSHOT (2024)             240

FIGURE 48            CARDINAL HEALTH: COMPANY SNAPSHOT (2024)    245

FIGURE 49            INTUITIVE SURGICAL: COMPANY SNAPSHOT (2024)    248

FIGURE 50            COLOPLAST A/S: COMPANY SNAPSHOT (2024)                 251

FIGURE 51            STRYKER: COMPANY SNAPSHOT (2024) 255

FIGURE 52            TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2024)             258

FIGURE 53            CONVATEC GROUP PLC: COMPANY SNAPSHOT (2024)    263

FIGURE 54            MEDTRONIC PLC: COMPANY SNAPSHOT (2024)                 265

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧